drugset / Trial / NCT02377492

Paracervical Vasopressin Injection Compared With Intramyometrial Vasopressin in Abdominal Myomectomy

NCT02377492

RandomizedSingle-groupTriple-blindPrevention

Summary

The goal of the investigators study is to evaluate the effectiveness of paracervical injection of vasopressin at the time of abdominal myomectomy to decrease blood loss. The investigators will continue to use intramyometrial vasopressin as this has previously been shown to be effective. The study will not exceed the safely documented dose of vasopressin.

Timeline

Start
2015-03
Primary completion
2017-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Vasopressin Peptide 8 iu Other

Indications